Manufacturers/Eugia US LLC

Eugia US LLC

67 drugs in NADAC|67 Generic,0 Brand

View Recalls (17)

Eugia US LLC lists 67 NDCs in the CMS NADAC file (67 generic, 0 brand), at an average NADAC of $12.95 per unit, with a week-over-week move of -1.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

67

67G / 0B

Avg Price / Unit

$12.9477

$0.07 – $197.61

Avg 7d Change

-1.03%

Across 39 drugs with changes

7d Activity

162328 flat

of 67 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Eugia US LLC make?

Eugia US LLC lists 67 NDCs in the CMS NADAC file — 67 generic and 0 brand products.

What is the average price of Eugia US LLC drugs?

The average NADAC across Eugia US LLC's portfolio is $12.9477 per unit, ranging from $0.0700 to $197.6060.

What types of drugs does Eugia US LLC make?

Eugia US LLC makes drugs across 29 FDA pharmacologic classes. The most common by NDC count are Amide Local Anesthetic (14), Antiarrhythmic (14), Corticosteroid (9), Penicillin-class Antibacterial (5), Factor Xa Inhibitor (4).

Has Eugia US LLC had any drug recalls?

17 FDA recalls are matched to Eugia US LLC in the openFDA feed, most recently on May 18, 2026.

How has Eugia US LLC's pricing changed recently?

Over the past 7 days, 16 Eugia US LLC products rose and 23 fell, with a portfolio-wide average change of -1.0%.

Drug Portfolio

67 drugs total, 67 shown

Drug Price 7d Change
LEUPROLIDE 2WK 14 MG/2.8 ML KT
LEUPROLIDE ACETATE
$197.6060
per EA
FONDAPARINUX 5 MG/0.4 ML SYR
FONDAPARINUX SODIUM
$55.3125
per ML
IBANDRONATE 3 MG/3 ML SYRINGE
Ibandronate Sodium
$54.2117
per ML
FONDAPARINUX 10 MG/0.8 ML SYR
FONDAPARINUX SODIUM
$45.3441
per ML
+2.32%
BORTEZOMIB 3.5 MG VIAL
BORTEZOMIB
$43.3460
per EA
FONDAPARINUX 7.5 MG/0.6 ML SYR
FONDAPARINUX SODIUM
$42.9123
per ML
-1.06%
FOSAPREPITANT 150 MG VIAL
FOSAPREPITANT DIMEGLUMINE
$38.5080
per EA
ERTAPENEM 1 GRAM VIAL
Ertapenem
$30.1598
per EA
+1.11%
ERTAPENEM 1 GRAM VIAL
Ertapenem
$30.1598
per EA
+1.11%
MEDROXYPROGESTERONE 150 MG/ML
MEDROXYPROGESTERONE ACETATE
$26.8952
per ML
+5.05%
AMPICILLIN-SULBACTAM 15 GM VL
Ampicillin Sodium and Sulbactam Sodium
$24.6333
per EA
OLANZAPINE 10 MG VIAL
OLANZAPINE
$22.1658
per EA
+1.32%
DAPTOMYCIN 500 MG VIAL
DAPTOMYCIN
$21.8463
per EA
MEDROXYPROGESTERONE 150 MG/ML
MEDROXYPROGESTERONE ACETATE
$21.2450
per ML
+4.07%
FONDAPARINUX 2.5 MG/0.5 ML SYR
FONDAPARINUX SODIUM
$20.8396
per ML
+5.98%
MEDROXYPROGESTERONE 150 MG/ML
MEDROXYPROGESTERONE ACETATE
$18.7597
per ML
-2.82%
SUMATRIPTAN 6 MG/0.5 ML VIAL
Sumatriptan
$14.9286
per ML
-0.87%
SUMATRIPTAN 6 MG/0.5 ML VIAL
Sumatriptan
$14.9286
per ML
-0.87%
NALOXONE 2 MG/2 ML SYRINGE
Naloxone Hydrochloride
$13.6929
per ML
+1.96%
METHYLPREDNISOLONE 400 MG/5 ML
Methylprednisolone Acetate
$13.4236
per ML
NALOXONE 4 MG/10 ML VIAL
NALOXONE HYDROCHLORIDE
$11.2094
per ML
TESTOSTERONE CYP 200 MG/ML
Testosterone Cypionate
$11.0289
per ML
-1.48%
FLUPHENAZINE DEC 125 MG/5 ML
FLUPHENAZINE DECANOATE
$9.7074
per ML
+2.32%
NALOXONE 0.4 MG/ML VIAL
Naloxone Hydrochloride
$8.0996
per ML
METHYLPREDNISOLONE 400 MG/10 ML
Methylprednisolone Acetate
$5.8078
per ML
EPHEDRINE SULFATE 50 MG/ML VL
Ephedrine Sulfate
$5.6366
per ML
TRIAMCINOLONE ACET 200 MG/5 ML
Triamcinolone Acetonide
$5.5980
per ML
TESTOSTERONE CYP 1,000 MG/10 ML
Testosterone Cypionate
$5.3573
per ML
-0.97%
MEROPENEM IV 1 GM VIAL
Meropenem
$5.1627
per EA
-5.10%
TRIAMCINOLONE ACET 400 MG/10 ML
Triamcinolone Acetonide
$5.1457
per ML
AMPICILLIN-SULBACTAM 3 GM VIAL
Ampicillin Sodium and Sulbactam Sodium
$4.3164
per EA
AMPICILLIN 1 GM VIAL
Ampicillin Sodium
$4.3059
per EA
AZITHROMYCIN I.V. 500 MG VIAL
Azithromycin
$3.5270
per EA
PIPERACIL-TAZOBACT 3.375 GM VL
Piperacillin Sodium and Tazobactam Sodium
$3.4926
per EA
TESTOSTERONE CYP 2,000 MG/10 ML
Testosterone Cypionate
$3.4614
per ML
+3.51%
AMPICILLIN 2 GM VIAL
Ampicillin Sodium
$3.2338
per EA
MEROPENEM IV 500 MG VIAL
Meropenem
$2.8678
per EA
THIAMINE 200 MG/2 ML VIAL
Thiamine Hydrochloride
$2.3916
per ML
-0.12%
PANTOPRAZOLE SODIUM 40 MG VIAL
Pantoprazole Sodium
$2.3740
per EA
DEXAMETHASONE 10 MG/ML VIAL
Dexamethasone Sodium Phosphate
$1.6516
per ML
-2.56%
PROGESTERONE 500 MG/10 ML VIAL
Progesterone
$1.4822
per ML
-1.11%
DEXAMETHASONE 4 MG/ML VIAL
DEXAMETHASONE SODIUM PHOSPHATE
$1.3879
per ML
GENTAMICIN 80 MG/2 ML VIAL
Gentamicin
$1.3618
per ML
-1.94%
DEXAMETHASONE 100 MG/10 ML VL
Dexamethasone Sodium Phosphate
$0.9309
per ML
LIDOCAINE HCL 1% 20 MG/2 ML VL
Lidocaine Hydrochloride
$0.8717
per ML
-0.42%
LIDOCAINE HCL 1% 20 MG/2 ML VL
Lidocaine Hydrochloride
$0.8717
per ML
-0.42%
KETAMINE 500 MG/10 ML VIAL
KETAMINE HYDROCHLORIDE
$0.5397
per ML
+2.98%
LIDOCAINE HCL 1% 50 MG/5 ML VL
Lidocaine Hydrochloride
$0.4538
per ML
-17.14%
LIDOCAINE HCL 1% 50 MG/5 ML VIAL
Lidocaine Hydrochloride
$0.4538
per ML
-17.14%
FUROSEMIDE 20 MG/2 ML VIAL
Furosemide
$0.4178
per ML
+0.58%
ROCURONIUM 50 MG/5 ML VIAL
Rocuronium Bromide
$0.3942
per ML
TRANEXAMIC ACID 1,000 MG/10 ML
Tranexamic Acid
$0.3603
per ML
-0.94%
LIDOCAINE HCL 2% 100 MG/5 ML
Lidocaine Hydrochloride
$0.3550
per ML
+0.96%
LIDOCAINE HCL 2% 100 MG/5 ML
Lidocaine Hydrochloride
$0.3550
per ML
+0.96%
ONDANSETRON 40 MG/20 ML VIAL
Ondansetron Hydrochloride
$0.3226
per ML
FUROSEMIDE 40 MG/4 ML VIAL
Furosemide
$0.3189
per ML
-6.67%
DEXAMETHASONE 120 MG/30 ML VL
DEXAMETHASONE SODIUM PHOSPHATE
$0.2276
per ML
ONDANSETRON HCL 4 MG/2 ML VIAL
Ondansetron Hydrochloride
$0.1968
per ML
DEXAMETHASONE 20 MG/5 ML VIAL
DEXAMETHASONE SODIUM PHOSPHATE
$0.1807
per ML
LIDOCAINE HCL 1% 100 MG/10 ML
Lidocaine Hydrochloride
$0.1320
per ML
+1.20%
LIDOCAINE HCL 1% VIAL
Lidocaine Hydrochloride
$0.1320
per ML
+1.20%
LIDOCAINE HCL 2% 400 MG/20 ML
Lidocaine Hydrochloride
$0.0878
per ML
-2.67%
LIDOCAINE HCL 2% VIAL
Lidocaine Hydrochloride
$0.0878
per ML
-2.67%
LIDOCAINE HCL 1% 300 MG/30 ML
Lidocaine Hydrochloride
$0.0712
per ML
-0.85%
LIDOCAINE HCL 1% 300 MG/30 ML
Lidocaine Hydrochloride
$0.0712
per ML
-0.85%
LIDOCAINE HCL 1% 200 MG/20 ML
Lidocaine Hydrochloride
$0.0700
per ML
-4.07%
LIDOCAINE HCL 1% VIAL
Lidocaine Hydrochloride
$0.0700
per ML
-4.07%

FDA Recalls (17)

Recalls matched by company name. Verify current status with FDA.

D-0552-2026
Ongoing
Class III

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Initiated: 5/18/2026
D-0472-2025
Ongoing
Class II

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Initiated: 5/29/2025
D-0390-2025
Ongoing
Class II

Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Initiated: 4/21/2025
D-0389-2025
Ongoing
Class II

Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Initiated: 4/21/2025
D-0363-2025
Ongoing
Class II

Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Initiated: 4/10/2025
D-0186-2025
Ongoing
Class II

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Initiated: 12/27/2024
D-0185-2025
Ongoing
Class II

medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India

CGMP Deviations

Initiated: 12/18/2024
D-0624-2024
Ongoing
Class II

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

Initiated: 7/26/2024
D-0555-2024
Ongoing
Class II

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Initiated: 5/23/2024
D-0556-2024
Ongoing
Class III

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Initiated: 5/22/2024
D-0385-2024
Terminated
Class II

Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.

Failed Stability Specification: Water determination was found not complying with specification.

Initiated: 2/22/2024
D-0366-2024
Ongoing
Class II

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Failed Dissolution Specifications

Initiated: 2/20/2024
D-0391-2024
Ongoing
Class II

Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Initiated: 2/20/2024
D-0390-2024
Ongoing
Class II

Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Initiated: 2/20/2024
D-0440-2024
Ongoing
Class I

Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10

Presence of Particulate Matter

Initiated: 2/15/2024
D-0041-2024
Ongoing
Class II

Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.

Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

Initiated: 9/28/2023
D-0095-2023
Ongoing
Class II

Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20

Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

Initiated: 12/28/2022